Shopping Cart
Remove All
Your shopping cart is currently empty
HLA-A*02:01&B2M&NPM1-CLAV (CLAVEEVSL) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled
(Synonyms: NPM1-CLAV (CLAVEEVSL), NPM1-CLAV, CLAVEEVSL) Copy Product InfoSynonyms: NPM1-CLAV (CLAVEEVSL), NPM1-CLAV, CLAVEEVSL
Catalog No. TMPK-01855 Copy Product Info
HLA-A*02:01&B2M&NPM1-CLAV (CLAVEEVSL) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled is expressed in E. coli. The accession number is A0A140T913(HLA-A*02:01)&P61769(B2M)&CLAVEEVSL.
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 µg | $355 | 7-10 days | 7-10 days | |
| 20 µg | $559 | 7-10 days | 7-10 days | |
| 50 µg | $987 | 7-10 days | 7-10 days | |
| 100 µg | $1,650 | 7-10 days | 7-10 days | |
| 200 µg | $2,630 | 7-10 days | 7-10 days | |
| 500 µg | $4,900 | 7-10 days | 7-10 days |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Storage & Solubility Information
| Bioactivity | Activity has not been tested. It is theoretically active, but we cannot guarantee it. |
| Description | HLA-A*02:01&B2M&NPM1-CLAV (CLAVEEVSL) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled is expressed in E. coli. The accession number is A0A140T913(HLA-A*02:01)&P61769(B2M)&CLAVEEVSL. |
| Species | Human |
| Expression System | E. coli |
| Tag | C-His-Avi |
| Accession Number | A0A140T913(HLA-A*02:01)&P61769(B2M)&CLAVEEVSL |
| Construction | Gly25-Thr305 (HLA-A*02:01), Ile21-Met119 (B2M) and CLAVEEVSL peptide |
| Formulation | Supplied as 0.22 μm filtered solution in 20 mM Tris, 200 mM NaCl, 0.2% BSA (pH 8.0). |
| Synonyms | NPM1-CLAV (CLAVEEVSL), NPM1-CLAV, CLAVEEVSL |
| Research Background | The nucleophosmin (NPM1) mutant protein, a leukemia-associated antigen characterized by its leukemia-restricted expression and immunogenic potential, has emerged as a promising therapeutic target for acute myeloid leukemia (AML) immunotherapy. Among its immunogenic epitopes, the CLAVEEVSL peptide derived from the full C-terminal region of the NPM1-mutated isoform demonstrates potent immunogenicity, making it a prime candidate for T cell-based immunotherapies. |
| Shipping | In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice. |
| Storage | It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Recombinant Proteins
Preview
Related Tags: HLA-A*02:01&B2M&NPM1-CLAV (CLAVEEVSL) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled chemical structure
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.